China National Medicines Corporation Ltd.
600511
Rank in Stocks
#4915
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Share Price
$3.96
Last synced: 2026-10-19
Market Cap
$2.99B
Change (1 day)
0.52%
Change (1 year)
-1.58%
Country
CN
Trade China National Medicines Corporation Ltd. (600511)
Category
Healthcare
Earnings for China National Medicines Corporation Ltd. (600511)
Earnings in Jun 2026 TTM: $364.66M
According to China National Medicines Corporation Ltd. latest financial reports the company's current earnings are $364.66M. In 2023 the company made an earning of $414.05M, an increase over its 2022 earnings that were of $389.67M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for China National Medicines Corporation Ltd. from 2000 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $364.66M | 0.30% |
| 2024 | $363.55M | -12.20% |
| 2023 | $414.05M | 6.26% |
| 2022 | $389.67M | 1.30% |
| 2021 | $384.65M | 31.06% |
| 2020 | $293.50M | -15.78% |
| 2019 | $348.48M | 18.48% |
| 2018 | $294.13M | 9.94% |
| 2017 | $267.54M | 18.23% |
| 2016 | $226.29M | 120.07% |
| 2015 | $102.83M | 1.91% |
| 2014 | $100.90M | 15.95% |
| 2013 | $87.02M | 28.00% |
| 2012 | $67.98M | 4.71% |
| 2011 | $64.92M | 26.10% |
| 2010 | $51.48M | 19.05% |
| 2009 | $43.24M | 17.69% |
| 2008 | $36.75M | 38.38% |
| 2007 | $26.56M | 79.82% |
| 2006 | $14.77M | 65.07% |
| 2005 | $8.95M | 30.75% |
| 2004 | $6.84M | 4.66% |
| 2003 | $6.54M | 21.97% |
| 2002 | $5.36M | 27.10% |
| 2001 | $4.22M | 35.00% |
| 2000 | $3.12M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $6.46B | 1,670.97% |
US
|
|
| - | - |
US
|
|
| $2.17B | 496.17% |
US
|
|
| - | - |
US
|
|
| $708.86M | 94.39% |
AU
|
